Apyx Medical Corp Effective Income Tax Rate Reconciliation, Tax Contingency, Percent
Apyx Medical Corp (APYX) reported Effective Income Tax Rate Reconciliation, Tax Contingency, Percent of 0.00% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies · last filed 2025-03-13
- Apyx Medical Corp effective income tax rate reconciliation, tax contingency, percent for fiscal 2024 was 0.00%, a 100.00% decline from fiscal 2023.
- Apyx Medical Corp effective income tax rate reconciliation, tax contingency, percent for fiscal 2023 was 9.80%.
- Apyx Medical Corp effective income tax rate reconciliation, tax contingency, percent for fiscal 2022 was -0.90%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent 12 month |
|---|---|
| 2024-12-31 | 0.00% 10-K · filed 2025-03-13 |
| 2023-12-31 | 9.80% 10-K · filed 2025-03-13 |
| 2022-12-31 | -0.90% 10-K · filed 2024-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |